Pertussis Vaccine Data Expected by Spring

Charles Marwick
JAMA. 1990;264(3):314. doi:10.1001/jama.1990.03450030028006.
Text Size: A A A
Published online


EVALUATION of a number of acellular pertussis vaccines, new and old, is under way.

More than 500 children have received one of 11 candidate vaccines or the present whole-cell product. John R. La Montagne, PhD, director, Microbiology and Infectious Diseases Division, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md, says enrollment of nearly 1600 children should be complete within 2 months and all the data may be available next March.

The vaccines include those that contain only the detoxified lymphocytosis promoting factor, both lymphocytosis promoting factor and another antigen of B pertussis (filamentous hemagglutinin), both these antigens plus a 69-kd protein from the surface of the organism, or a fourth antigen known as "agglutinogen-2." They come from manufacturers in Germany, France, Britain, Italy, Japan, and the United States.

The trial is the first effort by the congressionally mandated National Vaccine Program to improve existing vaccines


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours




Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.